Recipharm to change CEOs, spin out inhaler business

Re­ci­pharm CEO Marc Funk is step­ping down at the be­gin­ning of next year, and a for­mer Nestlé ex­ec­u­tive is set to take over as chief ex­ec­u­tive as the CD­MO pre­pares to spin off its in­haler busi­ness.

Greg Be­har has been the CEO of Nestlé Health Sci­ence since Ju­ly 2014, and he has held pre­vi­ous lead­er­ship po­si­tions at No­var­tis and Boehringer In­gel­heim.

Funk has served as CEO of Re­ci­pharm since March 2021 and will join the com­pa­ny’s board. Funk will con­tin­ue as CEO and board mem­ber of Mar­Bio, Re­ci­pharm and Mo­roc­co’s joint vac­cine man­u­fac­tur­ing site ini­ti­at­ed in Ju­ly 2021. He will al­so re­main on the board of New­Bi­ologix, a cell line en­gi­neer­ing busi­ness launched in May and fund­ed by Re­ci­pharm.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.